STOCK TITAN

Agilent Technologies Inc. - A STOCK NEWS

Welcome to our dedicated page for Agilent Technologies news (Ticker: A), a resource for investors and traders seeking the latest updates and insights on Agilent Technologies stock.

Agilent Technologies Inc., originally spun out of Hewlett-Packard in 1999, has evolved into a leading firm in the life sciences and diagnostics sector. The company specializes in creating advanced measurement technologies that serve a vast range of customers across various industries.

The company's core business revolves around three main segments: life science and applied tools, cross lab (which includes consumables and services related to life sciences and applied tools), and diagnostics and genomics. These segments collectively cater to a broad spectrum of markets, including biopharmaceuticals, chemicals, advanced materials, clinical labs, environmental testing, forensics, food safety, academic research, and government-related organizations.

Agilent's geographical reach is extensive, with significant operations in the U.S. and China. The company is committed to addressing global trends impacting human health and the environment and continuously anticipates future scientific needs.

Agilent provides comprehensive laboratory solutions that enhance the efficiency of laboratories, from sample preparation to data interpretation and management. Their instruments, software, services, and consumables are designed to meet the most complex laboratory demands, empowering scientists and researchers worldwide to make impactful discoveries and improvements in various fields.

Recent achievements include advancements in biopharmaceutical technology, collaborations with leading research institutions, and the launch of state-of-the-art diagnostic tools. The company also emphasizes sustainable practices and innovations aimed at improving human health and environmental outcomes.

Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) will participate in the AACR Annual Meeting to showcase new cell analysis, genomics, and companion diagnostics solutions. Key products include NovoCyte Opteon Spectral Flow Cytometer, Avida target enrichment solutions, SureSelect Cancer Custom panels, and SureSelect CD CiberMed panels. Agilent emphasizes its commitment to advancing cancer research and patient outcomes through innovative technologies and partnerships.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.31%
Tags
none
-
Rhea-AI Summary
Agilent Technologies Inc. and UC San Diego collaborate to establish the Agilent Center of Excellence in Cellular Intelligence. The CoE aims to improve understanding of disease mechanisms at the cellular level, drive cell editing methods for disease treatment, immunity enhancement, and bioproduct creation. The initiative will leverage Agilent's instrumentation to support the Decode Eukaryotic Cellular Intelligence research program.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.95%
Tags
none
-
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) introduces the Advanced Dilution System, ADS 2, an automation workflow solution to enhance laboratory efficiency. The system integrates with Agilent instruments and software, offering a comprehensive automated solution. With a focus on productivity and cost reduction, the ADS 2 optimizes analysis speed for various samples, ensuring data consistency and traceability.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.03%
Tags
none
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) reveals Joycelyn Tan, a Ph.D. student at the University of Cambridge, UK, as the recipient of the Agilent Thought Leader Award for her innovative research in metabolic science.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.77%
Tags
none
-
Rhea-AI Summary
Crawford & Company (CRD) releases Q4 2023 financial results with a revenue decrease of 8% compared to 2022. GAAP net loss improved to $(0.8) million from $(14.1) million in 2022 Q4. Non-GAAP net income was $3.3 million in 2023 Q4, down from $11.4 million in the previous year. Full year 2023 showed a 7% revenue increase over 2022, with net income of $30.6 million compared to a loss of $(18.3) million in 2022.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.04%
Tags
none
-
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) awards Distinguished Professors Michel Barsoum, Yury Gogotsi, and Ananda Amarasekara for their innovative research in advanced materials to enhance energy storage technology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.26%
Tags
none
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) reported Q1 revenue of $1.66 billion, down 5.6% reported and 6.4% core from last year. GAAP net income was $348 million, EPS $1.18, and non-GAAP net income $380 million, EPS $1.29. Full-year revenue outlook maintained at $6.710 - $6.810 billion with earnings guidance of $5.44 - $5.55 per share for FY 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.36%
Tags
-
Rhea-AI Summary
Agilent Technologies Inc. (A) declares a quarterly dividend of 23.6 cents per share of common stock, payable on April 24, 2024, to shareholders of record as of April 2, 2024, subject to board approval.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.45%
Tags
dividends
-
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) announces Padraig McDonnell as CEO-elect and COO, succeeding current CEO Mike McMullen. McDonnell, with nearly 40 years of experience, will take over on May 1, with McMullen retiring on Oct. 31. The transition reflects Agilent's strong leadership and succession planning.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.45%
Tags
none
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) has been recognized as one of the Most JUST Companies in America by Just Capital and CNBC for the sixth consecutive year. The company has consistently ranked in the top 50, showcasing its commitment to business issues important to the public, such as fair wages, job creation, and stakeholder accountability. Agilent's focus on ESG programs and community prosperity has earned it this prestigious recognition.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.93%
Tags
none

FAQ

What is the current stock price of Agilent Technologies (A)?

The current stock price of Agilent Technologies (A) is $133.84 as of November 22, 2024.

What is the market cap of Agilent Technologies (A)?

The market cap of Agilent Technologies (A) is approximately 38.0B.

What does Agilent Technologies Inc. specialize in?

Agilent specializes in life sciences, diagnostics, and measurement technologies, providing advanced solutions and services for laboratories.

When was Agilent Technologies Inc. founded?

Agilent Technologies was spun out of Hewlett-Packard in 1999.

What are the main business segments of Agilent Technologies Inc.?

Agilent operates in three main segments: life science and applied tools, cross lab, and diagnostics and genomics.

Which industries does Agilent Technologies Inc. serve?

Agilent serves industries such as biopharmaceuticals, chemicals, advanced materials, clinical labs, environmental testing, forensics, food safety, academic research, and government organizations.

Where are Agilent Technologies Inc.'s main operations located?

Agilent's main operations are located in the U.S. and China.

What recent achievements has Agilent Technologies Inc. made?

Recent achievements include advancements in biopharmaceutical technology, collaborations with research institutions, and new diagnostic tools.

How does Agilent Technologies Inc. contribute to laboratory efficiency?

Agilent enhances laboratory efficiency through comprehensive solutions for sample preparation, data interpretation, and management.

What sustainable practices does Agilent Technologies Inc. emphasize?

Agilent focuses on innovations that improve human health and environmental outcomes, emphasizing sustainability in its practices.

Why do scientists and researchers trust Agilent Technologies Inc.?

Scientists and researchers trust Agilent for its reliable solutions that meet complex laboratory demands and enable significant insights.

What kind of global issues does Agilent Technologies Inc. address?

Agilent addresses global issues related to human health and the environment, anticipating future scientific needs.

Agilent Technologies Inc.

NYSE:A

A Rankings

A Stock Data

38.05B
286.42M
0.27%
91.2%
1.2%
Diagnostics & Research
Laboratory Analytical Instruments
Link
United States of America
SANTA CLARA